Research Article
Bladder Carcinoma Data with Clinical Risk Factors and Molecular Markers: A Cluster Analysis
Table 5
Clinical and molecular characteristics of the different outliers (patient number).
| Attribute | Outlier 1 (13) | Outlier 2 (26) | Outlier 3 (30) | Outlier 4 (35) | Outlier 5 (37) | Outlier 6 (38) | Outlier 7 (44) | Outlier 8 (45) |
| Age | 77 | 73 | 69 | 72 | 41 | 71 | 80 | 60 |
Multiplicity | Yes | Yes | Yes | No | No | No | No | Yes | TM > 3 cm | Yes | No | No | No | No | No | Yes | Yes | Grade | G3 | G2 | G2 | G2 | G2 | G2 | G3 | G2 | TNM | T1 | Ta | Ta | Ta | T1 | T1 | T1 | Ta | Risk group | High | Low-Int | Low-Int | Low-Int | High | High | High | Low-Int | p53 | 0 | 4.7 | 0.9 | 0 | 0 | 0 | 0.9 | 0 | Neu | 2,125.80 | 724.5 | 415.8 | 459 | 994 | 700 | 385.7 | 870.6 | Egfr | 0.5 | 6.3 | 15.5 | 8.6 | 3.2 | 1.3 | 16.4 | 0 | GS (months) | 15 | 35 | 133 | 111 | 131 | 11 | 9 | 106 | RFS (months) | 15 | 11 | 5 | 11 | 59 | 1 | 3 | 18 | PFS (months) | 15 | 35 | 133 | 111 | 131 | 1 | 3 | 91 |
| Cluster | 4 | 3 | 3 | 3 | 2 | 4 | 4 | 3 |
|
|
Bold: reason for exclusion by the algorithm.
|